The ascent of acetylation in the epigenetics of rheumatoid arthritis

Nature Reviews Rheumatology

Volumn 9, Issue 5, 2013, Pages 311-318

  Grabiec, Aleksander M ^a   Reedquist, Kris A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; HISTONE DEACETYLASE; MICRORNA;

ACETYLATION; ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL POPULATION; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DISEASE PREDISPOSITION; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME REGULATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HISTONE MODIFICATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ACETYLATION; ADAPTIVE IMMUNITY; ANIMALS; ARTHRITIS, RHEUMATOID; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; IMMUNITY, INNATE;

EID: 84877602531     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.17     Document Type: Review

References (50)

1. Bogdanos, D. P.et al. Twin studies in autoimmune disease: genetics, gender and environment. J. Autoimmun. 38, J156-J169 (20126p
2. Bax, M. van Heemst, J., Huizinga, T. W. & Toes, R. E. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 63, 459-466 (20116p
3. Knevel, R.et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: A population-based study. Ann. Rheum. Dis. 71, 707-709 (20126p
4. Ballestar, E. Epigenetic alterations in autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 7, 263-271 (20116p
5. Huang, S The molecular and mathematical basis of Waddington's epigenetic landscape: A framework for post-Darwinian biology? Bioessays 34, 149-157 (20126p
6. Waddington, C. H. The epigenotype. Endeavour 1, 18-20 (19426p
7. Russo V. E., Martienssen R. A. & Riggs A. D. (Eds) Epigenetic Mechanisms of Gene Regulation (Cold Spring Harbor Laboratory Press, Woodbury, 19966p
8. Bottini, N. & Firestein, G. S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24-33 (20136p
9. Ospelt, C., Reedquist, K. A., Gay, S. & Tak, P. P. Inflammatory memories: Is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmun. Rev. 10, 519-524 (20116p
10. Jones, P. A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484-492 (20126p
11. Karouzakis, E.et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun. 12, 643-652 (20116p
12. Nakano, K., Whitaker, J. W., Boyle, D. L., Wang, W. & Firestein, G. S. DNA methylome signature in rheumatoid arthritis. Ann. Rheum. Dis. 72, 110-117 (20136p
13. Duroux-Richard, I., Jorgensen, C. & Apparailly, F. What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum. 64, 11-20 (20126p
14. Gardner, K. E.,Allis, C. D. & Strahl, B. D. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409, 36-46 (20116p
15. Yun, M., Wu, J., Workman, J. L. & Li, B. Readers of histone modifications. Cell Res. 21, 564-578 (20116p
16. Horiuchi, M.et al. Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. J. Rheumatol. 36, 1580-1589 (20096p
17. Huber, L. C.et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 56, 1087-1093 (20076p
18. Kawabata, T.et al. Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-α in synovial tissue of rheumatoid arthritis. Arthritis Res. Ther. 12, R133 (20106p
19. Grabiec, A. M., Tak, P. P. & Reedquist, K. A. Function of histone deacetylase inhibitors in inflammation. Crit Rev. Immunol. 31, 233-263 (20116p
20. Beier U.H.et al. Histone deacetylases 6 and 9 and sirtuin1 control FOXP3+ regulatory T cell function through shared and isoform-specific mechanisms Sci. Signal. 5 45 20126
21. de Zoeten, E. F., Wang, L., Sai, H., Dillmann, W. H. & Hancock, W. W. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138, 583-594 (20106p
22. de Zoeten, E. F.et al. Histone deacetylase 6 and heat shock protein 90 control the functions of FOXP3+ Tregulatory cells. Mol. Cell Biol. 31, 2066-2078 (20116p
23. Li, B.et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl Acad. Sci. USA 104, 4571-4576 (20076p
24. van Loosdregt J.et al. Regulation of TREG functionality by acetylation-mediated FOXP3 protein stabilization. Blood 115, 965-974 (20106p
25. van Loosdregt J.et al. Rapid temporal control of FOXP3 protein degradation by sirtuin1. PLoS ONE 6, e19047 (20116p
26. Navarro, M. N., Goebel, J., Feijoo-Carnero, C., Morrice, N. & Cantrell, D. A. Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nat. Immunol. 12, 352-361 (20116p
27. Barnes, P. J. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6, 693-696 (20096p
28. Grabiec, A. M.et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J. Immunol. 184, 2718-2728 (20106p
29. Niederer, F.et al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann. Rheum. Dis. 70, 1866-1873 (20116p
30. Gillespie, J.et al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3selective inhibitor reduces interleukin6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum. 64, 418-422 (20126p
31. Chen, X.et al. Requirement for the histone deacetylase HDAC3 for the inflammatory gene expression program in macrophages. Proc. Natl Acad. Sci. USA 109, E2865-E2874 (20126p
32. Mullican, S. E.et al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev. 25, 2480-2488 (20116p
33. Watson, P. J., Fairall, L., Santos, G. M. & Schwabe, J. W. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481, 335-340 (20126p
34. Prinjha, R. K., Witherington, J. & Lee, K. Place your BETs: The therapeutic potential of bromodomains. Trends Pharmacol. Sci. 33, 146-153 (20126p
35. Nicodeme, E.et al. Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119-1123 (20106p
36. Grabiec, A. M., Korchynskyi, O., Tak, P. P. & Reedquist, K. A. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL6 production by accelerating mRNA decay. Ann. Rheum. Dis. 71, 424-431 (20126p
37. Lundh, M.et al. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children. Diabetologia 55, 2421-2431 (20126p
38. Kruidenier, L.et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404-408 (20126p
39. Vojinovic, J.et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 63, 1452-1458 (20116p
40. US National Library of Medicine. ClinicalTrials.gov [online] http://clinicaltrials.gov/ct2/show/NCT01261624 (20126p
41. Bantscheff, M.et al. Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265 (20116p
42. Choudhary, C.et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 (20096p
43. Levy, D.et al. Lysine methylation of the NFκB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NFκB signaling. Nat. Immunol. 12, 29-36 (20116p
44. Gu, B. & Zhu, W. G. Surf the post-translational modification network of p53 regulation. Int. J. Biol. Sci. 8, 672-684 (20126p
45. Tanikawa, C.et al. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat. Commun. 3, 676 (20126p
46. Liu, X.et al. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc. Natl Acad. Sci. USA 108, 1925-1930 (20116p
47. Ptashne, M. On the use of the word 'epigenetic'. Curr. Biol. 17, R233-R236 (20076p
48. Bird, A. Perceptions of epigenetics. Nature 447, 396-398 (20076p
49. Das, J.et al. Digital signaling and hysteresis characterize Ras activation in lymphoid cells. Cell 136, 337-351 (20096p
50. Cotsapas C.et al. Pervasive sharing of genetic effects in autoimmune disease PLoS Genet. 7, e1002254 (20116p